M. Kunishige et al., INTERFERON ALPHA-2A THERAPY FOR DISSEMINATED INTRAVASCULAR COAGULATION IN A PATIENT WITH BLUE RUBBER BLEB NEVUS SYNDROME - A CASE-REPORT, Angiology, 48(3), 1997, pp. 273-277
The authors present a sixteen-year-old girl with blue rubber bleb nevu
s syndrome (BRBNS) associated with disseminated hemangiomas involving
the skin, oral cavity, skeletal muscle, and cerebrum. Although she den
ied neurologic symptoms, magnetic resonance imaging of the brain demon
strated dilatated cerebral veins and the Chiari I malformation. Examin
ation of hemostasis revealed disseminated intravascular coagulation (D
IG) manifesting as Kasabach-Merritt syndrome, with the potential for l
ife-threatening bleeding or thrombosis in the central nervous system.
Since successful management of life-threatening hemangiomas with inter
feron alpha-2a (IFN alpha-2a) has been reported, the authors administe
red IFN alpha-2a with an improvement in hemostasis. These findings sug
gest that IFN alpha-2a therapy is beneficial for relieving the life-th
reatening consumptive coagulopathy associated with BRBNS.